Analysis
| Earnings estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of analysts | 8 | 7 | 42 | 43 |
| Average estimate | 3.19 | 3.23 | 12.72 | 13.37 |
| Low estimate | 3.10 | 3.10 | 12.27 | 12.42 |
| High estimate | 3.40 | 3.40 | 13.20 | 14.80 |
| Last year EPS | 3.20 | 3.39 | 12.52 | 12.72 |
| Revenue estimate |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of Analysts | 6 | 6 | 42 | 42 |
| Avg. estimate | 232.02B | 236.18B | 911.84B | 961.23B |
| Low estimate | 226B | 230B | 886.90B | 906.89B |
| High estimate | 237B | 244.67B | 926.73B | 998.55B |
| Last year sales | 223.19B | 225.04B | 890.88B | 911.84B |
| Sales growth | 0.04 | 0.05 | 0.02 | 0.05 |
| EPS trend |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Current estimate | 3.19 | 3.23 | 12.72 | 13.37 |
| 7 days ago | 3.15 | 3.19 | 12.72 | 13.37 |
| 30 days ago | 3.17 | 3.19 | 12.70 | 13.39 |
| 60 days ago | 3.17 | 3.20 | 12.68 | 13.40 |
| 90 days ago | 3.17 | 3.20 | 12.67 | 13.40 |
| EPS revisions |
Current quarter (Dec 2025) |
Next quarter (Mar 2026) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Up last 7 days | 4 | 3 | 15 | 13 |
| Up last 30 days | 4 | 4 | 19 | 13 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 2 | 1 | 17 | 20 |
| Growth estimates | |
|---|---|
| Current qtr (Nov 2025) | -0.003% |
| Next qtr. (Feb 2026) | -0.048% |
| Current year (2025) | 0.016% |
| Next 5 years (per annum) | 0.053% |
| Past 5 years (per annum) | 0.074% |